These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30444977)

  • 41. In vitro activity of salinomycin and monensin derivatives against Trypanosoma brucei.
    Steverding D; Antoszczak M; Huczyński A
    Parasit Vectors; 2016 Jul; 9(1):409. PubMed ID: 27457761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanomolar Inhibitors of Trypanosoma brucei RNA Triphosphatase.
    Smith P; Ho CK; Takagi Y; Djaballah H; Shuman S
    mBio; 2016 Feb; 7(1):e00058-16. PubMed ID: 26908574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Atypical Mitochondrial Carrier That Mediates Drug Action in Trypanosoma brucei.
    de Macêdo JP; Schumann Burkard G; Niemann M; Barrett MP; Vial H; Mäser P; Roditi I; Schneider A; Bütikofer P
    PLoS Pathog; 2015 May; 11(5):e1004875. PubMed ID: 25946070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p97 Inhibitor CB-5083 Blocks ERAD in Trypanosoma brucei.
    Garrison P; Bangs JD
    Mol Biochem Parasitol; 2020 Sep; 239():111313. PubMed ID: 32735998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
    Merschjohann K; Steverding D
    Exp Parasitol; 2008 Apr; 118(4):637-40. PubMed ID: 18226810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing.
    Begolo D; Vincent IM; Giordani F; Pöhner I; Witty MJ; Rowan TG; Bengaly Z; Gillingwater K; Freund Y; Wade RC; Barrett MP; Clayton C
    PLoS Pathog; 2018 Sep; 14(9):e1007315. PubMed ID: 30252911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Singly and doubly modified analogues of C20-epi-salinomycin: A new group of antiparasitic agents against Trypanosoma brucei.
    Czerwonka D; Barcelos Y; Steverding D; Cioch A; Huczyński A; Antoszczak M
    Eur J Med Chem; 2021 Jan; 209():112900. PubMed ID: 33071053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toward More Drug Like Inhibitors of Trypanosome Alternative Oxidase.
    West RA; Cunningham T; Pennicott LE; Rao SPS; Ward SE
    ACS Infect Dis; 2018 Apr; 4(4):592-604. PubMed ID: 29353481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluating 5-Nitrothiazoles as Trypanocidal Agents.
    O'Shea IP; Shahed M; Aguilera-Venegas B; Wilkinson SR
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1137-40. PubMed ID: 26596950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei.
    Lu J; Vodnala SK; Gustavsson AL; Gustafsson TN; Sjöberg B; Johansson HA; Kumar S; Tjernberg A; Engman L; Rottenberg ME; Holmgren A
    J Biol Chem; 2013 Sep; 288(38):27456-27468. PubMed ID: 23900839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides.
    Artschwager R; Ward DJ; Gannon S; Brouwer AJ; van de Langemheen H; Kowalski H; Liskamp RMJ
    J Med Chem; 2018 Jun; 61(12):5395-5411. PubMed ID: 29782167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trypanocidal activity of aziridinyl nitrobenzamide prodrugs.
    Bot C; Hall BS; Bashir N; Taylor MC; Helsby NA; Wilkinson SR
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4246-52. PubMed ID: 20679506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense.
    Ebiloma GU; Ayuga TD; Balogun EO; Gil LA; Donachie A; Kaiser M; Herraiz T; Inaoka DK; Shiba T; Harada S; Kita K; de Koning HP; Dardonville C
    Eur J Med Chem; 2018 Apr; 150():385-402. PubMed ID: 29544150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei.
    Troeberg L; Morty RE; Pike RN; Lonsdale-Eccles JD; Palmer JT; McKerrow JH; Coetzer TH
    Exp Parasitol; 1999 Apr; 91(4):349-55. PubMed ID: 10092479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
    Mallari JP; Shelat A; Kosinski A; Caffrey CR; Connelly M; Zhu F; McKerrow JH; Guy RK
    Bioorg Med Chem Lett; 2008 May; 18(9):2883-5. PubMed ID: 18420405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic validation of aminoacyl-tRNA synthetases as drug targets in Trypanosoma brucei.
    Kalidas S; Cestari I; Monnerat S; Li Q; Regmi S; Hasle N; Labaied M; Parsons M; Stuart K; Phillips MA
    Eukaryot Cell; 2014 Apr; 13(4):504-16. PubMed ID: 24562907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
    Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
    Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents.
    Vicik R; Hoerr V; Glaser M; Schultheis M; Hansell E; McKerrow JH; Holzgrabe U; Caffrey CR; Ponte-Sucre A; Moll H; Stich A; Schirmeister T
    Bioorg Med Chem Lett; 2006 May; 16(10):2753-7. PubMed ID: 16516467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural Insights into the Development of Cycloguanil Derivatives as
    Landi G; Linciano P; Borsari C; Bertolacini CP; Moraes CB; Cordeiro-da-Silva A; Gul S; Witt G; Kuzikov M; Costi MP; Pozzi C; Mangani S
    ACS Infect Dis; 2019 Jul; 5(7):1105-1114. PubMed ID: 31012301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Trypanosoma brucei sphingolipid synthase, an essential enzyme and drug target.
    Mina JG; Pan SY; Wansadhipathi NK; Bruce CR; Shams-Eldin H; Schwarz RT; Steel PG; Denny PW
    Mol Biochem Parasitol; 2009 Nov; 168(1):16-23. PubMed ID: 19545591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.